Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model

A major goal for improving tuberculosis therapy is to identify drug regimens with improved efficacy and shorter treatment durations. Shorter therapies improve patient adherence to the antibiotic regimens, which, in turn, decreases resistance emergence. Mycobacterium tuberculosis exists in multiple m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Louie, Arnold, Duncanson, Brandon, Myrick, Jenny, Maynard, Michael, Nole, Jocelyn, Brown, David, Schmidt, Stephan, Neely, Michael, Scanga, C. A., Peloquin, Charles, Drusano, G. L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256764/
https://ncbi.nlm.nih.gov/pubmed/30249693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01470-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados